{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T21:12:18Z","timestamp":1762290738390,"version":"build-2065373602"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"DOI":"10.1186\/s13643-025-02889-x","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:10:49Z","timestamp":1762247449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Convergence of sociodemographic, clinical, regulatory, and quality characteristics in pharmacotherapeutic management of alcohol use disorder: a scoping review protocol"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9758-8856","authenticated-orcid":false,"given":"Raimundo Valdemy Borges","family":"Pinheiro Junior","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6015-3314","authenticated-orcid":false,"given":"Tiago","family":"Correia","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0289-4947","authenticated-orcid":false,"given":"Haliton Alves","family":"de Oliveira Junior","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6070-7233","authenticated-orcid":false,"given":"Gabriela Arantes","family":"Wagner","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"issue":"1","key":"2889_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41572-022-00406-1","volume":"8","author":"J MacKillop","year":"2022","unstructured":"MacKillop J, Agabio R, Feldstein Ewing SW, Heilig M, Kelly JF, Leggio L, Lingford-Hughes A, Palmer AA, Parry CD, Ray L, Rehm J. Hazardous drinking and alcohol use disorders. Nat Rev Dis Primers. 2022;8(1):80. https:\/\/doi.org\/10.1038\/s41572-022-00406-1.","journal-title":"Nat Rev Dis Primers."},{"key":"2889_CR2","unstructured":"World Health Organization. Global status report on alcohol and health 2018. Geneva: World Health Organization; 2018. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241565639"},{"issue":"8","key":"2889_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1176\/appi.ajp.20230488","volume":"180","author":"HR Kranzler","year":"2023","unstructured":"Kranzler HR. Overview of Alcohol Use Disorder. Am J Psychiatry. 2023;180(8):565\u201372. https:\/\/doi.org\/10.1176\/appi.ajp.20230488.","journal-title":"Am J Psychiatry"},{"key":"2889_CR4","unstructured":"World Health Organization. International standards for the treatment of drug use disorders. Geneva: WHO; 2020. Available from: https:\/\/www.who.int\/publications\/i\/item\/international-standards-for-the-treatment-of-drug-use-disorders"},{"issue":"Pt A","key":"2889_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109150","volume":"229","author":"A Roberts","year":"2021","unstructured":"Roberts A, Rogers J, Mason R, Siriwardena AN, Hogue T, Whitley GA, Law GR. Alcohol and other substance use during the COVID-19 pandemic: A systematic review. Drug Alcohol Depend. 2021;229(Pt A): 109150. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109150.","journal-title":"Drug Alcohol Depend"},{"key":"2889_CR6","unstructured":"United Nations Office on Drugs and Crime. World Drug Report 2021: Covid-19 and drugs. Vienna: UNODC; 2021. Available from: https:\/\/www.unodc.org\/res\/wdr2021\/field\/WDR21_Booklet_5.pdf"},{"issue":"2","key":"2889_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1176\/appi.ajp.2019.19121284","volume":"177","author":"ND Volkow","year":"2020","unstructured":"Volkow ND. Personalizing the Treatment of Substance Use Disorders. Am J Psychiatry. 2020;177(2):113\u20136. https:\/\/doi.org\/10.1176\/appi.ajp.2019.19121284.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"2889_CR8","doi-asserted-by":"publisher","first-page":"07","DOI":"10.35946\/arcr.v41.1.07","volume":"41","author":"BJ Mason","year":"2021","unstructured":"Mason BJ, Heyser CJ. Alcohol Use Disorder: The Role of Medication in Recovery. Alcohol Res. 2021;41(1):07. https:\/\/doi.org\/10.35946\/arcr.v41.1.07.","journal-title":"Alcohol Res."},{"issue":"4","key":"2889_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/08897077.2019.1576089","volume":"40","author":"SJ Haley","year":"2019","unstructured":"Haley SJ, Pinsker EA, Gerould H, Wisdom JP, Hagedorn HJ. Patient perspectives on alcohol use disorder pharmacotherapy and integration of treatment into primary care settings. Subst Abus. 2019;40(4):501\u20139. https:\/\/doi.org\/10.1080\/08897077.2019.1576089.","journal-title":"Subst Abus"},{"issue":"1","key":"2889_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13722-019-0151-7","volume":"14","author":"HJ Hagedorn","year":"2019","unstructured":"Hagedorn HJ, Wisdom JP, Gerould H, Pinsker E, Brown R, Dawes M, Dieperink E, Myrick DH, Oliva EM, Wagner TH, Harris AHS. Implementing alcohol use disorder pharmacotherapy in primary care settings: a qualitative analysis of provider-identified barriers and impact on implementation outcomes. Addict Sci Clin Pract. 2019;14(1):24. https:\/\/doi.org\/10.1186\/s13722-019-0151-7.","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"2889_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1370\/afm.2997","volume":"21","author":"A Bhardwaj","year":"2023","unstructured":"Bhardwaj A, Sousa JL, Huskamp HA, Busch AB, Kennedy-Hendricks A, Hodgkin D, Horgan C, Uscher-Pines L. Prescribing Medications for Alcohol Use Disorder: A Qualitative Study of Primary Care Physician Decision Making. Ann Fam Med. 2023;21(4):332\u20137. https:\/\/doi.org\/10.1370\/afm.2997.","journal-title":"Ann Fam Med"},{"issue":"1","key":"2889_CR12","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12913-022-07862-1","volume":"22","author":"T Philippine","year":"2022","unstructured":"Philippine T, Forsgren E, DeWitt C, Carter I, McCollough M, Taira BR. Provider perspectives on emergency department initiation of medication assisted treatment for alcohol use disorder. BMC Health Serv Res. 2022;22(1):456. https:\/\/doi.org\/10.1186\/s12913-022-07862-1.","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"2889_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/acem.14758","volume":"31","author":"E Forsgren","year":"2024","unstructured":"Forsgren E, Steiger A, Perez Y, Salazar D, McCollough M, Taira BR. Patient perspectives on emergency department initiation of medication for alcohol use disorder. Acad Emerg Med. 2024;31(5):471\u201380. https:\/\/doi.org\/10.1111\/acem.14758.","journal-title":"Acad Emerg Med"},{"issue":"4","key":"2889_CR14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s10488-020-01103-5","volume":"48","author":"KE Watkins","year":"2021","unstructured":"Watkins KE, Hunter SB, Cohen CC, Leamon I, Hurley B, McCreary M, Ober AJ. Organizational Capacity and Readiness to Provide Medication for Individuals with Co-Occurring Alcohol Use Disorders in Public Mental Health Settings. Adm Policy Ment Health. 2021;48(4):707\u201317. https:\/\/doi.org\/10.1007\/s10488-020-01103-5.","journal-title":"Adm Policy Ment Health"},{"issue":"3","key":"2889_CR15","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s11606-017-4202-z","volume":"33","author":"EC Williams","year":"2018","unstructured":"Williams EC, Achtmeyer CE, Young JP, Berger D, Curran G, Bradley KA, Richards J, Siegel MB, Ludman EJ, Lapham GT, Forehand M, Harris AHS. Barriers to and Facilitators of Alcohol Use Disorder Pharmacotherapy in Primary Care: A Qualitative Study in Five VA Clinics. J Gen Intern Med. 2018;33(3):258\u201367. https:\/\/doi.org\/10.1007\/s11606-017-4202-z.","journal-title":"J Gen Intern Med"},{"issue":"40","key":"2889_CR16","doi-asserted-by":"publisher","first-page":"e1364","DOI":"10.1503\/cmaj.230715","volume":"195","author":"E Wood","year":"2023","unstructured":"Wood E, Bright J, Hsu K, Goel N, Ross JWG, Hanson A, Teed R, Poulin G, Denning B, Corace K, Chase C, Halpape K, Lim R, Kealey T, Rehm J. Canadian Alcohol Use Disorder Guideline Committee.\u00a0Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder. CMAJ. 2023;195(40):e1364-E1379. https:\/\/doi.org\/10.1503\/cmaj.230715.","journal-title":"CMAJ."},{"issue":"1","key":"2889_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","volume":"175","author":"VI Reus","year":"2018","unstructured":"Reus VI, Fochtmann LJ, Bukstein O, Eyler AE, Hilty DM, Horvitz-Lennon M, Mahoney J, Pasic J, Weaver M, Wills CD, McIntyre J, Kidd J, Yager J, Hong SH. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder. Am J Psychiatry. 2018;175(1):86\u201390. https:\/\/doi.org\/10.1176\/appi.ajp.2017.1750101.","journal-title":"Am J Psychiatry"},{"key":"2889_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jsat.2017.09.002","volume":"82","author":"AHS Harris","year":"2017","unstructured":"Harris AHS, Brown R, Dawes M, Dieperink E, Myrick DH, Gerould H, Wagner TH, Wisdom JP, Hagedorn HJ. Effects of a multifaceted implementation intervention to increase utilization of pharmacological treatments for alcohol use disorders in the US Veterans Health Administration. J Subst Abuse Treat. 2017;82:107\u201312. https:\/\/doi.org\/10.1016\/j.jsat.2017.09.002.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"2889_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.12788\/jhm.2900","volume":"13","author":"JR Stephens","year":"2018","unstructured":"Stephens JR, Moore C, Stepanek KV, Garbutt JC, Starke B, Liles A, Jonas DE. Implementation of a Process for Initiating Naltrexone in Patients Hospitalized for Alcohol Detoxification or Withdrawal. J Hosp Med. 2018;13(4):221\u20138. https:\/\/doi.org\/10.12788\/jhm.2900.","journal-title":"J Hosp Med."},{"issue":"5","key":"2889_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1177\/08404704211027183","volume":"34","author":"I Szelest","year":"2021","unstructured":"Szelest I, Harries B, Motluk L, Harries J. How prescribing available pharmacotherapies for alcohol use disorder can impact the healthcare system: A retrospective quality improvement study. Healthc Manage Forum. 2021;34(5):283\u201390. https:\/\/doi.org\/10.1177\/08404704211027183.","journal-title":"Healthc Manage Forum"},{"issue":"6","key":"2889_CR21","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.annemergmed.2021.05.013","volume":"78","author":"ES Anderson","year":"2021","unstructured":"Anderson ES, Chamberlin M, Zuluaga M, Ullal M, Hawk K, McCormack R, D\u2019Onofrio G, Herring AA. Implementation of Oral and Extended-Release Naltrexone for the Treatment of Emergency Department Patients with Moderate to Severe Alcohol Use Disorder: Feasibility and Initial Outcomes. Ann Emerg Med. 2021;78(6):752\u20138. https:\/\/doi.org\/10.1016\/j.annemergmed.2021.05.013.","journal-title":"Ann Emerg Med"},{"issue":"8","key":"2889_CR22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1176\/appi.ps.201400329","volume":"66","author":"A Williamson","year":"2015","unstructured":"Williamson A, Makkar SR, McGrath C, Redman S. How Can the Use of Evidence in Mental Health Policy Be Increased? A Systematic Review Psychiatr Serv. 2015;66(8):783\u201397. https:\/\/doi.org\/10.1176\/appi.ps.201400329.","journal-title":"A Systematic Review Psychiatr Serv"},{"issue":"10","key":"2889_CR23","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.sapharm.2017.11.014","volume":"14","author":"SN Silva","year":"2018","unstructured":"Silva SN, Lima MG, Ruas CM. Pharmaceutical interventions in mental health: A review of the literature to support evidence-informed policymaking. Res Social Adm Pharm. 2018;14(10):891\u2013900. https:\/\/doi.org\/10.1016\/j.sapharm.2017.11.014.","journal-title":"Res Social Adm Pharm"},{"issue":"7","key":"2889_CR24","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/heapol\/czad038","volume":"38","author":"C Brooks","year":"2023","unstructured":"Brooks C, Mirzoev T, Chowdhury D, Deuri SP, Madill A. Using evidence in mental health policy agenda-setting in low- and middle-income countries: a conceptual meta-framework from a scoping umbrella review. Health Policy Plan. 2023;38(7):876\u201393. https:\/\/doi.org\/10.1093\/heapol\/czad038.","journal-title":"Health Policy Plan"},{"key":"2889_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","volume":"8","author":"H Arksey","year":"2005","unstructured":"Arksey H, O\u2019Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19\u201332. https:\/\/doi.org\/10.1080\/1364557032000119616.","journal-title":"Int J Soc Res Methodol"},{"issue":"10","key":"2889_CR26","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","volume":"18","author":"MDJ Peters","year":"2020","unstructured":"Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, McInerney P, Godfrey CM, Khalil H. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18(10):2119\u201326. https:\/\/doi.org\/10.11124\/JBIES-20-00167.","journal-title":"JBI Evid Synth."},{"issue":"1","key":"2889_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. https:\/\/doi.org\/10.1186\/2046-4053-4-1.","journal-title":"Syst Rev"},{"issue":"7","key":"2889_CR28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373. https:\/\/doi.org\/10.7326\/M18-0850.","journal-title":"Ann Intern Med"},{"issue":"16","key":"2889_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12874-016-0116-4","volume":"9","author":"AC Tricco","year":"2016","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien K, Colquhoun H, Kastner M, et al. A scoping review on the conduct and reporting of scoping reviews. BMC Med Res Methodol. 2016;9(16):15. https:\/\/doi.org\/10.1186\/s12874-016-0116-4.","journal-title":"BMC Med Res Methodol"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-025-02889-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-025-02889-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-025-02889-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T21:04:14Z","timestamp":1762290254000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-025-02889-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2889"],"URL":"https:\/\/doi.org\/10.1186\/s13643-025-02889-x","relation":{},"ISSN":["2046-4053"],"issn-type":[{"type":"electronic","value":"2046-4053"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"14 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statements and patient consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publications"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}